STOCKWATCH
·
Pharmaceuticals
New Launch28 Feb 2026, 03:04 pm

Blue Jet Healthcare Initiates Phase 1 of Vizag Manufacturing Facility with Board-Approved Investment of 31,000 Crore

AI Summary

Blue Jet Healthcare marked the ground-breaking of its Vizag manufacturing facility in the presence of Hon’ble Minister for IT, Electronics & Communications and HRD, Shri Nara Lokesh. The Company’s Board of Directors has approved Phase 1 of the project with an investment of approximately 1,000 crore. The facility is envisaged as a multi-phase development with a long-term investment potential of up to 2,300 crore, subject to business milestones, regulatory approvals, and subsequent Board approvals. The Vizag facility will focus on the manufacture of complex pharmaceutical intermediates and active pharmaceutical ingredients (APIs), strengthening Blue Jet Healthcare’s capabilities as a global supplier to pharmaceutical innovators. The project aligns with Andhra Pradesh’s industrial development objectives and supports India’s broader agenda of strengthening advanced manufacturing and supply-chain resilience.

Key Highlights

  • Blue Jet Healthcare initiates Phase 1 of Vizag Manufacturing Facility with a Board-Approved Investment of 31,000 Crore.
  • The facility is envisaged as a multi-phase development with a long-term investment potential of up to 2,300 crore.
  • The Vizag facility will focus on the manufacture of complex pharmaceutical intermediates and active pharmaceutical ingredients (APIs).
  • The project aligns with Andhra Pradesh’s industrial development objectives.
  • The project supports India’s broader agenda of strengthening advanced manufacturing and supply-chain resilience.
BLUEJET
Pharmaceuticals
Blue Jet Healthcare Ltd

Price Impact